The dosage of IR alfuzosin hydrochloride ranges from 2.5 mg p.o. thrice daily to a maximum of 10-12 mg/day. Frequent daily administration is required because of alfuzosin's short serum half-life.
To better determine the onset of symptom relief with alfuzosin 10 mg q.d. in men with symptomatic BPH, we conducted a short-term, randomized, controlled clinical trial. For this investigation, we used ...
The chemistry, pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of alfuzosin hydrochloride in the treatment of benign prostatic hyperplasia (BPH) are discussed. Alfuzosin is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results